| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/24/2002 | WO2001034132A3 Use of an aldosterone antagonist for treating restenosis |
| 01/24/2002 | WO2001032157A3 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 01/24/2002 | WO2001032154A3 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 01/24/2002 | WO2001030331A3 Therapeutic compositions including protein kinase c inhibitors |
| 01/24/2002 | WO2001029037A3 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001023387A3 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 01/24/2002 | WO2001022936A8 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001013908A3 Tissue volume reduction |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2001010454A3 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2001006987A3 Transnasal anticonvulsive compositions and modulated process |
| 01/24/2002 | WO2001003682B1 Use of pyridoxin derivatives for the treatment of diabetes and related complications |
| 01/24/2002 | WO2000071107A8 New pharmaceutical combinations for nos inhibitors |
| 01/24/2002 | WO2000066142A3 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 01/24/2002 | WO2000053168A3 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 01/24/2002 | US20020010693 Integrated hangtag production system |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010216 Mixture of norepinephrine reuptake inhibitors and antimuscarinic agents; treating disorders or diseases of the central nervous system, and particularly useful in treating incontinence. |
| 01/24/2002 | US20020010212 Assay for D-serine transport antagonist and use for treating psychosis |
| 01/24/2002 | US20020010210 Pharmaceutical preparation and method for treating cancer |
| 01/24/2002 | US20020010205 Treating alopecia |
| 01/24/2002 | US20020010198 Treatment of eating disorders, obesity, irritable bowel syndrome, obsessive-compulsive disorders, platelet adhesion, male and female sexual function disorders, restless leg syndrome, osteoarthritis |
| 01/24/2002 | US20020010197 Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity |
| 01/24/2002 | US20020010194 Administering intranasally a local anesthetic selected from bupivacaine and ropivacaine |
| 01/24/2002 | US20020010192 Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 01/24/2002 | US20020010165 Treating the hypercalcemia associated with malignant or neoplastic cells with an effective amount of a hypocalcemic vitamin D compound having a hydrocarbon moiet at the 24 position |
| 01/24/2002 | US20020010158 Derivatives of 5-pyridylalkylphosphonates and 5-pyridylalkylmalonates useful drugs for treatment of cardiovascular related diseases and diabetes mellitus related diseases |
| 01/24/2002 | US20020010150 Homostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 01/24/2002 | US20020010149 Therapeutic agent for a cancer and method of screening the same, and health-care auxiliary food |
| 01/24/2002 | US20020010148 Oral combinations of hydroxocobalamin and folic acid |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020010133 Method for preventing gastritis using amylin or amylin agonists |
| 01/24/2002 | US20020010128 Treating atopic dermatitis and/or skin photodamage, by administering a HMG-CoA reductase (3-hydroxy-3-methylglutaryl coenzyme A reductase) inhibitor |
| 01/24/2002 | US20020010125 Chemokinesis interferes with immune and inflammatory responses by increasing cell movements and altering cell migration patterns; interfere with spread of malignant cells through the body, and reduce inflammatory responses |
| 01/24/2002 | US20020009802 Removing preferential microorganism from sample; obtain sample, incubate with prophylactic agent, monitor sample for presence of microorganism |
| 01/24/2002 | US20020009743 That proliferate in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, where certain proportion of cells are committed to form neuronal cells, glial cells, or both; screening compounds |
| 01/24/2002 | US20020009740 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 01/24/2002 | US20020009506 Plant extracts, herbs, natural nutritional supplements, minerals and vitamins |
| 01/24/2002 | US20020009505 Compositions and methods for treating eye discomfort |
| 01/24/2002 | US20020009504 Herbs, natural nutritional supplements, minerals, vitamins and plant extracts; antiinflammatory agents |
| 01/24/2002 | US20020009502 Water, sodium chloride, potassium chloride, sodium citrate, potassium citrate, carbohydrates and structuring agents; masks unpleasant tastes |
| 01/24/2002 | US20020009491 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
| 01/24/2002 | US20020009450 Administering antagonist to surface receptors |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009439 Central nervous system disorders therapy; genetic engineered culture; Alzheimer's disease |
| 01/24/2002 | US20020009433 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 01/24/2002 | US20020009423 Using hydroxyacid or tannic acid |
| 01/24/2002 | DE10045374A1 Sustained release microparticles and their preparation using a multi-emulsion process, for delivery of drugs for up to 6 months or longer |
| 01/24/2002 | DE10033717A1 Kosmetische und dermatologische Zubereitung zur Beseitigung von Sebum Cosmetic and dermatological preparation for the removal of sebum |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2418162A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 01/24/2002 | CA2418146A1 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416487A1 Stimulation of bone growth with thrombin peptide derivatives |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2416120A1 Methods and formulations with probiotic microorganisms and medicaments |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415697A1 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415392A1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | CA2413582A1 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/23/2002 | EP1174151A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 01/23/2002 | EP1174136A2 Oral pharmaceutical dosage form containing a proton pump inhibitor |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1174129A1 Use of a matrix-metalloprotease inhibitor for the treatment of cancer |
| 01/23/2002 | EP1174108A1 Cosmetics |
| 01/23/2002 | EP1173766A1 A tenascin-c isoform as a marker for neoplasias |
| 01/23/2002 | EP1173757A1 Diagnosis of human kidney diseases |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173562A2 Inhibition of histone deacetylase |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173548A2 Materials and methods relating to neuronal development |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173470A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173254A2 Novel treatment of neurotraumatic conditions with a raf inhibitor |
| 01/23/2002 | EP1173253A1 Contraceptive compositions containing cyclic carbamates and amide derivatives |